Revisiting the Lyme Disease Serodiagnostic Algorithm: the Momentum Gathers

Area of Science:

• Medical Diagnostics
• Infectious Diseases
• Microbiology

Background:

• Lyme disease, caused by Borrelia burgdorferi, is a prevalent tick-borne illness in the US.
• The standard two-tiered (STT) algorithm for Lyme disease diagnosis has limitations, including low sensitivity in early stages.
• Western blotting (WB), a component of the STT, presents practical challenges.

Purpose of the Study:

• To evaluate modified two-tiered (MTT) algorithms for Lyme disease serodiagnosis.
• To compare the sensitivity and specificity of MTT algorithms against the STT algorithm.
• To assess the potential of MTT for improved early Lyme disease detection.

Main Methods:

• Evaluation of three specific MTT algorithms: Liaison VlsE CLIA, Captia B. burgdorferi IgG/IgM EIA, and C6 B. burgdorferi (Lyme) EIA.
• Comparison with the STT algorithm using enzyme-linked immunoassay (EIA) or immunofluorescence assay (IFA) as the first tier and ViraStripe IgM and IgG WBs as the second tier.
• Analysis of diagnostic performance metrics including sensitivity and specificity.

Main Results:

• All evaluated MTT algorithms demonstrated higher sensitivity compared to the STT algorithm for Lyme disease diagnosis.
• The MTT algorithms maintained high specificity, ensuring accurate disease identification.
• MTT approaches proved to be a valid alternative to the current STT diagnostic strategy.

Conclusions:

• Modified two-tiered algorithms offer a superior alternative to the standard two-tiered algorithm for Lyme disease serodiagnosis.
• The improved sensitivity of MTT algorithms facilitates earlier detection of Lyme disease.
• These findings pave the way for developing rapid and point-of-care diagnostic tests for Lyme disease.